Pharma doctor spend pays off for branded scripts
Doctors receiving payments were almost twice as likely to prescribe three brand name gabapentinoids, study shows
15th July 2019
Paying doctors speaker fees or shouting them a meal appear to have paid off for the marketers of brand name gabapentinoids, US research suggests.
Doctors who received pharma company payments were almost twice as likely to prescribe the branded versions of the drugs than those who received no money, says a research letter in JAMA Internal Medicine.
Researchers from Yale University and the University of Connecticut examined the association between pharma payments and physician
